Experience in using the VI-RADS system in assessing the depth of invasion of bladder tumors

Author:

Kaprin A. D.1ORCID,Rubtsova N. A.2ORCID,Kabanov D. O.2ORCID,Golbits A. B.2ORCID,Vorobyev N. V.3ORCID,Pilchuk P. S.2ORCID

Affiliation:

1. Moscow Research Oncological Institute named after P.A. Herzen – branch of “National Medical Research Center of Radiology”, Ministry of Healthcare of Russia; Medical institute of the Peoples' Friendship University of Russia

2. Moscow Research Oncological Institute named after P.A. Herzen – branch of “National Medical Research Center of Radiology”, Ministry of Healthcare of Russia

3. Moscow Research Oncological Institute named after P.A. Herzen – branch of “National Medical Research Center of Radiology”, Ministry of Healthcare of Russia; I.M. Sechenov First Moscow State Medical University (Sechenov University)

Abstract

Introduction. Survival rates and treatment algorithms for patients with bladder cancer (BC) depend on the depth of tumor invasion, in particular on the presence of the bladder muscle layer invasion and extraorganic spread. To assess the depth of bladder invasion, the VI-RADS system was developed in 2018, which is based on multiparametric MRI (mpMRI). According to published studies on the VI-RADS effectiveness, there is a high diagnostic accuracy for identifying formations with probable invasion into the muscle layer. The data on BC extraorganic spread are limited and the issue of assessing the sensitivity and specificity of this system requires further study.Aim of the study. To evaluate the diagnostic performance of mpMRI using the VI-RADS system in detecting muscle invasion and BC extraorganic growth.Materials and methods. A prospective study was conducted in the clinics of the National Medical Research Radiological Centre and included 75 patients aged 19 to 85 years, of which 39 (52%) had been newly diagnosed with BC, 36 (48%) had a relapse or continuous tumor growth. All patients underwent pelvic organs mpMRI on a tomograph with a magnetic field induction of 1.5T, followed by transurethral resection (TUR), TUR-biopsy of the bladder or cystectomy no later than 6 weeks after scanning.. The description of the bladder tumor included its measurements, localization and VI-RADS scale assessment. The data obtained by mpMRI were compared with the results of the morphological study using statistical analysis.Results. According to the results of the study, the overall VI-RADS scale sensitivity for categories above 3 (the presence of muscle invasion is equivocal) was 95.15% [90.11%; 99.95%], above 4 (muscle invasion is likely) – 92.59% [82.11%; 97.94%], specificity was determined at the level of 47.62% [25.71%; 70.22%] and 80.95% [58.09%; 94.55%] respectively. When assessing extraorganic spread in 30 patients, the sensitivity was 83.33% [62.62%; 95.26%], specificity – 83.33% [35.88%; 99.58%]. The accuracy and positive predictive value also had high levels from 80 to 95%, in contrast to the negative predictive value (55.56%).Conclusion. The scale for BC invasion depth assessing VI-RADS is characterized by high rates of sensitivity, specificity and accuracy, in particular when used in determining extraorganic spread.

Publisher

Vidar, Ltd.

Subject

Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Reference30 articles.

1. Bladder cancer, 2020. Russian clinical guidelines (Russian National Union “Association of Oncologists of Russia”, Russian Public Organization “Russian Society of Urological Oncology”, Russian Public Organization “Russian Society of Clinical Oncology”, Russian Public Organization “Russian Society of Urologists”) (In Russian)

2. IARC, Cancer Today. Estimated number of new cases in 2020, worldwide, both sexes, all ages. 2021.

3. The state of cancer care in Russia in 2020 / Eds Каprin А.D., Starinskiy V.V., Shakhzadova A.O. М.: Moscow Research Oncological Institute named after P.A. Herzen, 2021. 239 p. (In Russian)

4. Burger M., Catto J.W., Dalbagni G. et al. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 2013; 63 (2): 234–241. https://doi.org/10.1016/j.eururo.2012.07.033

5. Stenzl A., Cowan N.C., European Association of Urology (EAU) et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur. Urol. 2011; 59 (6): 1009–1018. https://doi.org/10.1016/j.eururo.2011.03.023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3